Phosphoglycerate kinase 1 promoting tumor progression and metastasis in gastric cancer - Detected in a tumor mouse model using positron emission tomography/magnetic resonance imaging

Cellular Physiology and Biochemistry

Volumn 26, Issue 2, 2010, Pages 147-154

  Zieker, Derek ^a   Königsrainer, Ingmar ^a   Weinreich, Jürgen ^a   Beckert, Stefan ^a   Glatzle, Jörg ^a   Nieselt, Kay ^b   Bühler, Sarah ^a   Löffler, Markus ^a   Gaedcke, Jochen ^c   Northoff, Hinnak ^a   Mannheim, Julia G ^c   Wiehr, Stefan ^c   Pichler, Bernd J ^c   Von Weyhern, Claus ^c   Brücher, Björn L D M ^a   Königsrainer, Alfred ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Department of Information and Cognitive Sciences   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cancer dissemination; Cancer imaging; CXCR4; Gastric cancer; Metastasis; Peritoneal carcinomatosis; PET MRI; PGK1

Indexed keywords

PHOSPHOGLYCERATE KINASE; PHOSPHOGLYCERATE KINASE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR GROWTH;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 78049323312     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320545     Document Type: Article

References (19)

1. Parkin DM, Pisani P, Ferlay J: Global cancer statistics. CA Cancer J Clin 1999;49:33-64.
2. Yasumoto K, Koizumi K, Kawashima A, Saitoh Y, Arita Y, Shinohara K, Minami T, Nakayama T, Sakurai H, Takahashi Y, Yoshie O, Saiki I: Role of the CXCL12/ CXCR4 axis in peritoneal carcinomato-sis of gastric cancer. Cancer Res 2006;66:2181-2187.
3. Bando E, Yonemura Y, Takeshita Y, Taniguchi K, Yasui T, Yoshimitsu Y, Fushida S, Fujimura T, Nishimura G, Miwa K: Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg 1999;178:256-262.
4. Gonzalez-Moreno S, Gonzalez-Bayon L, Ortega-Perez G, Gonzalez-Hernando C: Imaging of peritoneal carcinomatosis. Cancer J 2009;15:184-189.
5. Funicelli L, Travaini LL, Landoni F, Trifiro G, Bonello L, Bellomi M: Peritoneal carcinomatosis from ovarian cancer: the role of CT and [(18)F]FDG-PET/ CT. Abdom Imaging 2009, in press.
6. Pfannenberg C, Konigsrainer I, Aschoff P, Oksuz MO, Zieker D, Beckert S, Symons S, Nieselt K, Glatzle J, Weyhern CV, Brucher BL, Claussen CD, Königsrainer A: (18)F-FDG-PET/CT to select patients with peritoneal carcino-matosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 2009;16:1295-1303.
7. Antoch G, Bockisch A: Combined PET/ MRI: a new dimension in whole-body oncology imaging? Eur J Nucl Med Mol Imaging 2009;36 Suppl 1:113-120.
8. Heiken JP: Contrast safety in the cancer patient: preventing contrast-induced ne-phropathy. Cancer Imaging 2008;8 Spec No A:124-127.
9. Zieker D, Konigsrainer I, Traub F, Nieselt K, Knapp B, Schillinger C, Stirnkorb C, Fend F, Northoff H, Kupka S, Brucher BL, Konigsrainer A: PGK1 a potential marker for peritoneal dissemination in gastric cancer. Cell Physiol Biochem 2008;21:429-436.
10. Wang J, Wang J, Dai J, Jung Y, Wei CL, Wang Y, Havens AM, Hogg PJ, Keller ET, Pienta KJ, Nor JE, Wang CY, Taichman RS: A glycolytic mechanism regulating an angiogenic switch in prostate cancer. Cancer Res 2007;67:149-159.
11. Daly EB, Wind T, Jiang XM, Sun L, Hogg PJ: Secretion of phosphoglycerate kinase from tumour cells is controlled by oxygen-sensing hydroxylases. Biochim Biophys Acta 2004;1691:17-22.
12. Duan Z, Lamendola DE, Yusuf RZ, Penson RT, Preffer FI, Seiden MV: Overexpression of human phosphoglyc-erate kinase 1 (PGK1) induces a multidrug resistance phenotype. Anticancer Res 2002;22:1933-1941.
13. Hwang TL, Liang Y, Chien KY, Yu JS: Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma. Proteomics 2006;6:2259-2272.
14. Zhang D, Tai LK, Wong LL, Chiu LL, Sethi SK, Koay ES: Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer. Mol Cell Proteomics 2005;4:1686-1696.
15. Zieker D, Königsrainer I, Tritschler I, Löffler M, Beckert S, Traub F, Nieselt K, Bühler S, Weller M, Gaedcke J, Taichman RS, Northoff H, Brücher BL, Königsrainer A: Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer. Int J Cancer 2010;126:1513-1520.
16. Hobbs S, Jitrapakdee S, Wallace JC: Development of a bicistronic vector driven by the human polypeptide chain elongation factor 1alpha promoter for creation of stable mammalian cell lines that express very high levels of recombinant proteins. Biochem Biophys Res Commun 1998;252:368-372.
17. Bhargava S, Hotz B, Buhr HJ, Hotz HG: An orthotopic nude mouse model for preclinical research of gastric cardia cancer. Int J Colorectal Dis 2009;24:31-39.
18. Warburg O: On respiratory impairment in cancer cells. Science 1956;124:269-270.
19. Judenhofer MS, Wehrl HF, Newport DF, Catana C, Siegel SB, Becker M, Thielscher A, Kneilling M, Lichy MP, Eichner M, Klingel K, Reischl G, Widmaier S, Röcken M, Nutt RE, Machulla HJ, Uludag K Cherry SR, Claussen CD, Pichler BJ: Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med 2008;14:459-465.